Literature DB >> 28526623

AllergoOncology: IgE- and IgG4-mediated immune mechanisms linking allergy with cancer and their translational implications.

Erika Jensen-Jarolim1, Michelle C Turner2, Sophia N Karagiannis3.   

Abstract

Entities:  

Keywords:  AllergoOncology; Allergy; IgE; antibody-dependent cell-mediated cytotoxicity; cancer; clinical oncology; effector cells; oncoimmunology; tolerance; tumor

Mesh：

Substances：

Year:  2017        PMID： 28526623     DOI： 10.1016/j.jaci.2017.04.034

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN： 0091-6749            Impact factor:   10.793


× No keyword cloud information.
  12 in total

Review 1.  IgE Antibodies against Cancer: Efficacy and Safety.

Authors:  Jitesh Chauhan; Alex J McCraw; Mano Nakamura; Gabriel Osborn; Heng Sheng Sow; Vivienne F Cox; Chara Stavraka; Debra H Josephs; James F Spicer; Sophia N Karagiannis; Heather J Bax
Journal:  Antibodies (Basel)       Date:  2020-10-16

Review 2.  B Cell Intrinsic Mechanisms Constraining IgE Memory.

Authors:  Brice Laffleur; Orianne Debeaupuis; Zeinab Dalloul; Michel Cogné
Journal:  Front Immunol       Date:  2017-11-13       Impact factor: 7.561

3.  Engineering and stable production of recombinant IgE for cancer immunotherapy and AllergoOncology.

Authors:  Silvia Crescioli; Giulia Chiaruttini; Silvia Mele; Kristina M Ilieva; Giulia Pellizzari; Daniel I R Spencer; Richard A Gardner; Katie E Lacy; James F Spicer; Andrew N J Tutt; Gerd K Wagner; Sophia N Karagiannis
Journal:  J Allergy Clin Immunol       Date:  2018-01-31       Impact factor: 10.793

Review 4.  The Role of IgG4 in the Fine Tuning of Tolerance in IgE-Mediated Allergy and Cancer.

Authors:  Rodolfo Bianchini; Sophia N Karagiannis; Galateja Jordakieva; Erika Jensen-Jarolim
Journal:  Int J Mol Sci       Date:  2020-07-16       Impact factor: 5.923

5.  Remodeling of the tumor microenvironment via disrupting Blimp1+ effector Treg activity augments response to anti-PD-1 blockade.

Authors:  Michael L Dixon; Lin Luo; Sadashib Ghosh; Jeffrey M Grimes; Jonathan D Leavenworth; Jianmei W Leavenworth
Journal:  Mol Cancer       Date:  2021-11-20       Impact factor: 27.401

6.  Clinical and immunological allergy assessment in cancer patients.

Authors:  Bruno Gustavo Muzzi Carvalho Carneiro; Andy Petroianu; José Augusto Nogueira Machado; Paula Martins Ferreira Dos Anjos; Fabiana Rocha da Silva; Luiz Ronaldo Alberti; Vivian Resende; Sofia Candia Barrientos
Journal:  Sci Rep       Date:  2021-09-13       Impact factor: 4.379

Review 7.  AllergoOncology: Opposite outcomes of immune tolerance in allergy and cancer.

Authors:  E Jensen-Jarolim; H J Bax; R Bianchini; S Crescioli; T R Daniels-Wells; D Dombrowicz; E Fiebiger; H J Gould; S Irshad; J Janda; D H Josephs; F Levi-Schaffer; L O'Mahony; G Pellizzari; M L Penichet; F Redegeld; F Roth-Walter; J Singer; E Untersmayr; L Vangelista; S N Karagiannis
Journal:  Allergy       Date:  2017-10-05       Impact factor: 13.146

8.  IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance.

Authors:  Rodolfo Bianchini; Franziska Roth-Walter; Anna Ohradanova-Repic; Sabine Flicker; Karin Hufnagl; Michael Bernhard Fischer; Hannes Stockinger; Erika Jensen-Jarolim
Journal:  Allergy       Date:  2018-11-28       Impact factor: 13.146

9.  AllergoOncology: High innate IgE levels are decisive for the survival of cancer-bearing mice.

Authors:  Josef Singer; Gertrude Achatz-Straussberger; Anna Bentley-Lukschal; Judit Fazekas-Singer; Gernot Achatz; Sophia N Karagiannis; Erika Jensen-Jarolim
Journal:  World Allergy Organ J       Date:  2019-07-29       Impact factor: 4.084

Review 10.  IgE Antibodies: From Structure to Function and Clinical Translation.

Authors:  Brian J Sutton; Anna M Davies; Heather J Bax; Sophia N Karagiannis
Journal:  Antibodies (Basel)       Date:  2019-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.